Study shows MicroPulse® laser controls IOP after keratoplasty
VANCOUVER, British Columbia — Use of MicroPulse transscleral cyclophotocoagulation in patients after keratoplasty resulted in IOP control and minimal complications, according to a presentation here at the Association for Research in Vision and Ophthalmology meeting.
Jessica Minjy Kang, MD, and colleagues from the University of California, San Francisco, Department of Ophthalmology conducted a retrospective observational study of glaucoma patients with a history of penetrating keratoplasty (16 eyes) or Descemet’s stripping automated endothelial keratoplasty (14 eyes) who failed medical therapy and then were treated with MicroPulse transscleral cyclophotocoagulation (Iridex).
Patients were an average of 66 years old with an average baseline IOP of 27.7 mm Hg. They were followed for an average of 10.5 months, Kang said in her presentation. IOP, number of glaucoma medications, best corrected visual acuity and central corneal thickness were measured at baseline and 1, 3, 6 and 12 months postoperatively.
To read the Full Article, Click Here!